Deutsche Bank’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-3,268
| Closed | -$42K | – | 4666 |
|
|
2019
Q4 | $42K | Sell |
3,268
-4,911
| -60% | -$63.1K | ﹤0.01% | 3922 |
|
|
2019
Q3 | $85K | Sell |
8,179
-14,647
| -64% | -$152K | ﹤0.01% | 3558 |
|
|
2019
Q2 | $386K | Sell |
22,826
-11,252
| -33% | -$190K | ﹤0.01% | 3403 |
|
|
2019
Q1 | $1.15M | Buy |
34,078
+1,058
| +3% | +$35.6K | ﹤0.01% | 2887 |
|
|
2018
Q4 | $963K | Buy |
33,020
+18,248
| +124% | +$532K | ﹤0.01% | 2897 |
|
|
2018
Q3 | $910K | Buy |
14,772
+822
| +6% | +$50.6K | ﹤0.01% | 3367 |
|
|
2018
Q2 | $1.03M | Sell |
13,950
-3,721
| -21% | -$274K | ﹤0.01% | 3372 |
|
|
2018
Q1 | $1.16M | Buy |
17,671
+6,668
| +61% | +$437K | ﹤0.01% | 3185 |
|
|
2017
Q4 | $924K | Buy |
11,003
+2,425
| +28% | +$204K | ﹤0.01% | 3194 |
|
|
2017
Q3 | $990K | Sell |
8,578
-754
| -8% | -$87K | ﹤0.01% | 2976 |
|
|
2017
Q2 | $1.09M | Buy |
9,332
+2,577
| +38% | +$300K | ﹤0.01% | 2933 |
|
|
2017
Q1 | $832K | Buy |
6,755
+235
| +4% | +$28.9K | ﹤0.01% | 2723 |
|
|
2016
Q4 | $886K | Buy |
6,520
+76
| +1% | +$10.3K | ﹤0.01% | 2740 |
|
|
2016
Q3 | $1.28M | Buy |
6,444
+61
| +1% | +$12.1K | ﹤0.01% | 2626 |
|
|
2016
Q2 | $825K | Buy |
6,383
+1,292
| +25% | +$167K | ﹤0.01% | 2973 |
|
|
2016
Q1 | $475K | Buy |
5,091
+388
| +8% | +$36.2K | ﹤0.01% | 3193 |
|
|
2015
Q4 | $953K | Sell |
4,703
-11,904
| -72% | -$2.41M | ﹤0.01% | 2853 |
|
|
2015
Q3 | $2.41M | Buy |
16,607
+8,357
| +101% | +$1.21M | ﹤0.01% | 2343 |
|
|
2015
Q2 | $1.75M | Buy |
8,250
+2,150
| +35% | +$457K | ﹤0.01% | 2535 |
|
|
2015
Q1 | $1.41M | Sell |
6,100
-3,809
| -38% | -$882K | ﹤0.01% | 2640 |
|
|
2014
Q4 | $2.28M | Buy |
+9,909
| New | +$2.28M | ﹤0.01% | 2550 |
|